NCT04692818
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: Female
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must be scheduled for a clinically-indicated biopsy
Exclusions: Patients with previous breast surgery or breast implant; Patients currently receiving cancer therapy such as chemotherapy or radiation therapy
https://ClinicalTrials.gov/show/NCT04692818